Navigation Links
Polaroid Wide and Long Electrophoresis Hood from Bio-Rad

ProductsPolaroid Wide and Long Electrophoresis Hood from Bio-Rad
Company Bio-Rad
Item Polaroid Wide and Long Electrophoresis Hood
Price 
Description The wide and long electrophoresis hood is a component of Polaroid gel documentation systems. Placed on the transilluminator, it holds the camera in place and provides a darkroom environment that allows photography on the lab bench. This 15.2 x 22.9 cm hood provides 0.45x magnification.
Info Bio-RadBio-Rad
Bio-Rad Laboratories, Inc.
Life Science Research Group
2000 Alfred Nobel Drive
Hercules, CA 94547
USA
Customer Service: 800-424 6723
Fax Number: 800-879 2289
Web Site: http://discover.bio-rad.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Polaroid Standard Electrophoresis Hood from Bio-Rad
2. Polaroid B&W positive, 3 x 4 inch pack film, 20 exp from Hoefer, Inc.
3. 10X Capillary Electrophoresis Running Buffer from Sigma-Aldrich
4. Paragon CZE 2000 Capillary Electrophoresis System from Beckman Coulter
5. Mini Horizontal Electrophoresis Unit i-MyRun.NC from Cosmo Bio Co., Ltd.
6. Marker for 2D Electrophoresis from Sigma-Aldrich
7. Capillary Electrophoresis System from Agilent Technologies
8. E-Gel96 High-Throughput Agarose Electrophoresis System from Invitrogen
9. Essential Techniques: Gel Electrophoresis: Proteins from Promega
10. Essential Data: Gel Electrophoresis from Promega
11. Electrophoresis Loading Dye, 6X from Research Organics, Inc.
Rat PTX2 / SAP, Unconjugated from R&D Systems
HybriWell™ hybridization sealing system, 22 mm x 22 mm chamber, 0.15 mm deep *set of 100* from Molecular Probes (Invitrogen)
HybriWell™ hybridization sealing system, 20 mm diameter chamber, 0.15 mm deep *set of 100* from Molecular Probes (Invitrogen)
Feline IL-5, Unconjugated from R&D Systems
Biology Products:
(Date:12/2/2009)...D SHORES, Calif. and PALM HARBOR, Fla., Dec. 2 /PR...Corporation ("CIC") (OTC Bulletin Board: CICI), a ... for business process automation in the financial ... signature verification and Docubase Systems Inc. ...ocument Management (EDM) software provider announc...
(Date:12/2/2009)...nt at the University of Southampton,s School of Oc...ography Centre, Southampton (NOCS) has formally de...e deep sea. , Hall discovered the new species in...m of Natural History in Washington. Explaining the...nclude some of the largest crustaceans currently i...
(Date:12/1/2009)...Calif., Dec. 1 GestureTek Inc. tod... a turnkey, portable, plug and play interactive pr... entertainment and touring promotions. GestureTek ... camera-enabled gesture recognition technology for...nt systems. ,, Guaranteed for quality, the CUBE...
Breaking Biology News(10 mins):CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 4King crab family bigger than ever 2GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 2Group Health Cooperative Scored Above Regional Average in 11 of 15 Quality Measures 52086 1Group Health Cooperative Scored Above Regional Average in 11 of 15 Quality Measures 52086 2Advance Research Associates Joins DATATRAKs CRO Connect Program 28TM 29 52083 1Advance Research Associates Joins DATATRAKs CRO Connect Program 28TM 29 52083 2Advance Research Associates Joins DATATRAKs CRO Connect Program 28TM 29 52083 3Advance Research Associates Joins DATATRAKs CRO Connect Program 28TM 29 52083 4 Contrave 28R 29 Obesity Research Phase 3 Program Meets Co Primary and Key Secondary Endpoints 3B Exceeds FDA Efficacy Benchmark for Obesity Treatment 52080 1 Contrave 28R 29 Obesity Research Phase 3 Program Meets Co Primary and Key Secondary Endpoints 3B Exceeds FDA Efficacy Benchmark for Obesity Treatment 52080 2 Contrave 28R 29 Obesity Research Phase 3 Program Meets Co Primary and Key Secondary Endpoints 3B Exceeds FDA Efficacy Benchmark for Obesity Treatment 52080 3 Contrave 28R 29 Obesity Research Phase 3 Program Meets Co Primary and Key Secondary Endpoints 3B Exceeds FDA Efficacy Benchmark for Obesity Treatment 52080 4 Contrave 28R 29 Obesity Research Phase 3 Program Meets Co Primary and Key Secondary Endpoints 3B Exceeds FDA Efficacy Benchmark for Obesity Treatment 52080 5 Contrave 28R 29 Obesity Research Phase 3 Program Meets Co Primary and Key Secondary Endpoints 3B Exceeds FDA Efficacy Benchmark for Obesity Treatment 52080 6 Contrave 28R 29 Obesity Research Phase 3 Program Meets Co Primary and Key Secondary Endpoints 3B Exceeds FDA Efficacy Benchmark for Obesity Treatment 52080 7 Contrave 28R 29 Obesity Research Phase 3 Program Meets Co Primary and Key Secondary Endpoints 3B Exceeds FDA Efficacy Benchmark for Obesity Treatment 52080 8 Contrave 28R 29 Obesity Research Phase 3 Program Meets Co Primary and Key Secondary Endpoints 3B Exceeds FDA Efficacy Benchmark for Obesity Treatment 52080 9
...nto researchers have uncovered the basis by which ...and have also discovered how the HIV virus works t... to improved vaccines for pregnant women in malari...se spread by mosquitoes that kills more than one m...s mostly children, malaria also severely affects p...
...ted by researchers from the University of Verona a...irms the pivotal role played by Cytomegalovirus in...Atherosclerosis is the main cause of morbidity and...ng smoking, diabetes, hypertension and high choles...he pathogenesis of the disease that also recognise...
...otic drug used in emergency rooms to treat methamp...f the brain known to regulate movement, a new stud...with rats, indicate that only the combination of t...uses the destructive effects, not either one alone...at Boston University School of Medicine suspect th...
Other Biology News:HIV and malaria combine to adversely affect pregnant women and their infants 2Cytomegalovirus exacerbates atherosclerosis through an autoimmune mechanism 2Common treatment for methamphetamine overdose may damage brain cells 2
(Date:12/1/2009)..., NEW YORK, Dec. 1 Reportlinker.c...available in its catalogue: ,, Industrial Enzy...portlinker.com/p0164431/Industrial-Enzymes---A-Glo...arket is an oligopoly with few strong players and ...activities. Keen competition and commoditization c...
(Date:12/1/2009)...MOUTH, Mass., Dec. 1 Harvest Techn...day results from the company sponsored 60-patient ...l Center in Chennai, India using the company,s BMA...e Critical Limb Ischemia (CLI). Sri Ramachandra Me...sociated institution based in Chennai, India and o...
(Date:12/1/2009)... Former Majority Leader Richard Gephardt Brings T..., Biotech Communities for "Best and Brightest For...., Dec. 1 Several of Ne...icals, research, medicine and technology gathered ... importance of medical innovation in New Jersey, a...
(Date:12/1/2009)...ARASOTA, Fla., Dec. 1 Expanding it...otechnics Inc. of Sarasota has appointed Lake Chem..., Lake is located near Birmingham, England. ,... which serve the agricultural, waste water, and en...ungry and to open drain fields, and clean up indus...
Breaking Biology Technology:Reportlinker Adds Industrial Enzymes - A Global Market Report 2Reportlinker Adds Industrial Enzymes - A Global Market Report 3Reportlinker Adds Industrial Enzymes - A Global Market Report 4Reportlinker Adds Industrial Enzymes - A Global Market Report 5Reportlinker Adds Industrial Enzymes - A Global Market Report 6Reportlinker Adds Industrial Enzymes - A Global Market Report 7Reportlinker Adds Industrial Enzymes - A Global Market Report 8Reportlinker Adds Industrial Enzymes - A Global Market Report 9Reportlinker Adds Industrial Enzymes - A Global Market Report 10Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 2Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia 3New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 2New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 3New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 4New Jersey's Best and Brightest Minds Discuss Challenges Facing Medical Innovation, Call for Policies to Preserve U.S. Leadership in Research and Development 5